Shigella infection
Showing 1 - 25 of >10,000
Immunisation, Shigella Infection Trial in Cincinnati (Placebo, Shigella sonnei strain 53G, WRSs2)
Recruiting
- Immunisation
- Shigella Infection
- Placebo
- +2 more
-
Decatur, Georgia
- +1 more
Feb 2, 2023
Shigella Infection, Enterotoxigenic Escherichia Coli Infection Trial in Baltimore (strain CVD 1208S-122, Placebo)
Not yet recruiting
- Shigella Infection
- Enterotoxigenic Escherichia Coli Infection
- strain CVD 1208S-122
- Placebo
-
Baltimore, MarylandUniversity of Maryland, Baltimore, University of Maryland School
Jul 26, 2022
Shigellosis Trial in Kilifi (Shigella sonnei 53G, Ciprofloxacin 500 mg)
Not yet recruiting
- Shigellosis
- Shigella sonnei 53G
- Ciprofloxacin 500 mg
-
Kilifi, KenyaKEMRI-Wellcome Trust Research Programme
Jul 17, 2023
Shigella Trial in Baltimore (SF2a-TT15 Shigella Vaccine, Placebo, S. flexneri 2a strain 2457T Challenge Agent)
Recruiting
- Shigella
- SF2a-TT15 Shigella Vaccine
- +2 more
-
Baltimore, MarylandUniversity of Maryland, Baltimore, Center for Vaccine Developmen
May 5, 2022
Shigella Trial in Baltimore (CVD 1208S, a Shigella flexneri 2a live, oral vaccine, Placebo)
Terminated
- Shigella
- CVD 1208S, a Shigella flexneri 2a live, oral vaccine
- Placebo
-
Baltimore, MarylandUniversity of Maryland, Baltimore Center for Vaccine Development
Apr 27, 2021
Shigella Trial in Baltimore (CVD 1208S, a Shigella flexneri 2a live, oral vaccine, Placebo)
Completed
- Shigella
- CVD 1208S, a Shigella flexneri 2a live, oral vaccine
- Placebo
-
Baltimore, Maryland
- +1 more
Apr 27, 2021
Shigellosis Trial in Baltimore (S. sonnei 53G, S. flexneri 2a 2457T)
Recruiting
- Shigellosis
- S. sonnei 53G
- S. flexneri 2a 2457T
-
Baltimore, MarylandCenter for Immunization Research (CIR) at Johns Hopkins School o
Dec 15, 2021
Weight Gain, Anemia, Iron Deficiency, Birth Weight Trial in Mataram (Egg intervention)
Recruiting
- Weight Gain
- +16 more
- Egg intervention
-
Mataram, West Nusa Tenggara, IndonesiaAikmel, Sakra, and Sikur Subdistrict
Mar 17, 2021
Enterics for Global Health (EFGH)
Recruiting
- Shigella
- +2 more
-
Dhaka, Bangladesh
- +32 more
Sep 18, 2023
Shigellosis Trial in Dhaka (Tebipenem Pivoxil, Azithromycin, Ceftriaxon)
Recruiting
- Shigellosis
- Tebipenem Pivoxil
- +2 more
-
Dhaka, BangladeshInternational Centre for Diarrhoeal Disease Research, Bangladesh
Jan 18, 2023
Dysentery, Bacillary Trial in Cincinnati (S.sonnei vaccine, Placebo, S. sonnei 53G challenge strain)
Completed
- Dysentery, Bacillary
- S.sonnei vaccine
- +2 more
-
Cincinnati, OhioGSK Investigational Site
Jul 16, 2020
Healthy Volunteers Trial in Dhaka (ShigETEC live, attenuated, oral vaccine, Placebo)
Not yet recruiting
- Healthy Volunteers
- ShigETEC live, attenuated, oral vaccine
- Placebo
-
Dhaka, BangladeshInternational Centre for Diarrhoeal Diseases Research, Banglades
Aug 3, 2023
Diarrheal Disease, Infectious, Gastrointestinal Disease, Reactive Arthritis Trial in Debrecen (ShigETEC live, attenuated, oral
Completed
- Diarrheal Disease, Infectious
- +2 more
- ShigETEC live, attenuated, oral vaccine
- Placebo
-
Debrecen, HungaryDebreceni Egyetem, Klinikai Központ, Belgyógyászati Klinika, Kli
Jun 3, 2022
Shigella Trial in Baltimore (CVD 1208S, Challenge strain of wild-type Shigella flexneri 2a)
Terminated
- Shigella
- CVD 1208S, Challenge strain of wild-type Shigella flexneri 2a
-
Baltimore, Maryland
- +1 more
Apr 27, 2021
Multidrug Resistant Shigella Infection in Bangladesh
Unknown status
- Diarrhea
- Shigella
-
Dhaka, BangladeshInternational Centre for Diarrhoeal Disease Research
Jan 25, 2019
Diarrhea Bloody Trial in Calgary (BioFire Gastrointestinal Panel FilmArray®, Standard of Care)
Completed
- Diarrhea Bloody
- BioFire Gastrointestinal Panel FilmArray®
- Standard of Care
-
Calgary, Alberta, CanadaAlberta Children's Hospital
Nov 1, 2022
Shigella Infection Trial in Cincinnati (Placebo, WRSs2, WRSs3)
Completed
- Shigella Infection
- Placebo
- +2 more
-
Cincinnati, OhioCincinnati Children's Hospital Medical Center - Infectious Disea
Jan 24, 2019
Sanitation and Oral Rotavirus Vaccine Performance
Recruiting
- Rotavirus Infections
- +2 more
- Sanitation
-
Maputo, MozambiqueCentro de Investigação em Saúde da Polana Caniço (CISPOC)
May 16, 2022
Healthy Volunteer Trial (CampETEC HBC product, ProMilk 85, C. jejuni CG8421 Challenge strain)
Not yet recruiting
- Healthy Volunteer
- CampETEC HBC product
- +2 more
- (no location specified)
Nov 7, 2023
Shigellosis Trial in Baltimore (Flexyn2a, Placebo)
Completed
- Shigellosis
- Flexyn2a
- Placebo
-
Baltimore, MarylandJohns Hopkins Bloomberg School of Public Health, CIR
Jan 7, 2021
Shigellosis, Bacillary Dysentery Trial in Leiden (2.5 µg InvaplexAR-Detox, 10 µg InvaplexAR-Detox, 0.1 µg of dmLT)
Not yet recruiting
- Shigellosis
- Bacillary Dysentery
- 2.5 μg InvaplexAR-Detox
- +3 more
-
Leiden, NetherlandsLeiden University Medical Center
Jul 26, 2023
Antimicrobial Resistance Trial in Nanoro (Two-step malaria RDT detecting PfHRP2/pLDH (SD Ag Bioline Malaria Ag P.f/Pan: Standard
Recruiting
- Antimicrobial Resistance
- Two-step malaria RDT detecting PfHRP2/pLDH (SD Ag Bioline Malaria Ag P.f/Pan: Standard Diagnostics, Hagal-Dong, Korea)
-
Nanoro, Boulkiemde, Burkina Faso
- +1 more
Mar 14, 2022
Shigellosis Trial in Baltimore (Vaccine: 2.6±0.8 x 10^8 vp/mL, 1 dose, Vaccine: 2.6±0.8 x 10^9 vp/mL, 3 doses, Vaccine: 2.6±0.8
Completed
- Shigellosis
- Vaccine: 2.6±0.8 x 10^8 vp/mL, 1 dose
- +4 more
-
Baltimore, Maryland
- +1 more
Aug 10, 2021
Acute Febrile Illness, Use of Antimicrobial Agents, C-reactive Protein Level Trial (C-reactive Protein Rapid Diagnostic Test)
Not yet recruiting
- Acute Febrile Illness
- +2 more
- C-reactive Protein Rapid Diagnostic Test
- (no location specified)
Dec 23, 2022
Diarrhea Trial in Silver Spring (Invaplex[AR-DETOX], Placebo)
Completed
- Diarrhea
- Invaplex[AR-DETOX]
- Placebo
-
Silver Spring, MarylandWalter Reed Army Institute of Research Clinical Trials Center (W
Jul 7, 2021